Evidence map›Paper›PMID 37200714›Full record

ArticleJPGN reports2023

A Novel

Ahmed H Al Sharie, Balqis M Abu Mousa, Yazan O Al Zu'bi, Mohammad A Al Qudah, Saied A Jaradat, Ahmad Barakat, Eyad Altamimi

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JPGN reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ahmed H Al SharieFrom the Faculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Balqis M Abu MousaFrom the Faculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Yazan O Al Zu'biFrom the Faculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Mohammad A Al QudahFaculty of Medicine, Hashemite University, Zarqa, Jordan.
Saied A JaradatDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Ahmad BarakatDepartment General Surgery and Urology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Eyad AltamimiDepartment of Pediatrics and Neonatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Jordan University of Science and Technology · JOHashemite University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anoctamin 1 (ANO1)-related intestinal dysmotility syndrome (OMIM: 620045) is an extremely rare disorder with only 2 cases reported in the medical literature. We present the clinical scenario of a 2-month-old male infant that presented to our center with diarrhea, vomiting, and abdominal distension. Routine investigations did not yield a clear diagnosis. Whole-exome sequencing showed a novel homozygous nonsense

Indexed as

ANO1intestinal dysmotility syndromenovel mutation

Identifiers

PMID37200714
PMCPMC10187830
OpenAlexW4375945364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.